(Total Views: 338)
Posted On: 01/17/2021 11:04:41 AM
Post# of 36547
As Joe said in the CC announcement:
In addition, I will
update everyone on our progress and timing on the NuGenerex Immuno-Oncology
Nasdaq listing now that our third-party valuation analysis has been completed with a
value estimated at over $500 million. This third-party valuation report is the last piece of
information required to enable us to set the price per share to meet the standards for
the Nasdaq.
In addition, I will
update everyone on our progress and timing on the NuGenerex Immuno-Oncology
Nasdaq listing now that our third-party valuation analysis has been completed with a
value estimated at over $500 million. This third-party valuation report is the last piece of
information required to enable us to set the price per share to meet the standards for
the Nasdaq.
(2)
(0)Scroll down for more posts ▼
